Nektar to Announce Financial Results for the Third Quarter on Thursday, November 6, 2025, After Close of U.S.-Based Financial Markets
Nektar (Nasdaq:NKTR) will announce its third-quarter 2025 financial results on Thursday, November 6, 2025 after the U.S. market close. Howard Robin, President and CEO, will host a conference call at 5:00 p.m. ET / 2:00 p.m. PT to review results. A press release and an audio-only webcast link will be posted on the company's investor relations site at https://ir.nektar.com/. The web broadcast replay will be available through December 6, 2025. Investors must pre-register to receive dial-in details and a PIN to access the live call.
Nektar (Nasdaq:NKTR) annuncerà i propri risultati finanziari del terzo trimestre 2025 giovedì 6 novembre 2025 dopo la chiusura del mercato statunitense. Howard Robin, Presidente e CEO, condurrà una conference call alle 17:00 ET / 14:00 PT per rivedere i risultati. Un comunicato stampa e un link a una webcast solo audio saranno pubblicati sul sito delle relazioni con gli investitori dell’azienda all’indirizzo https://ir.nektar.com/. La riproduzione della trasmissione web sarà disponibile fino al 6 dicembre 2025. Gli investitori devono preregistrarsi per ricevere i dettagli del dial-in e un PIN per accedere alla chiamata in diretta.
Nektar (Nasdaq:NKTR) anunciará sus resultados financieros del tercer trimestre de 2025 el jueves 6 de noviembre de 2025 después del cierre del mercado de Estados Unidos. Howard Robin, Presidente y CEO, dirigiará una conferencia telefónica a las 5:00 p.m. ET / 2:00 p.m. PT para revisar los resultados. Se publicará un comunicado de prensa y un enlace a una webcast solo de audio en el sitio de relaciones con inversores de la empresa en https://ir.nektar.com/. La reproducción de la transmisión web estará disponible hasta el 6 de diciembre de 2025. Los inversores deben preregistrarse para recibir los detalles de acceso telefónico y un PIN para la llamada en vivo.
Nektar(Nasdaq:NKTR)은 2025년 3분기 실적을 2025년 11월 6일 목요일 미국 주식시장 마감 후 발표합니다. Howard Robin, 회장 겸 CEO가 동부 표준시 5:00 p.m. / 태평양 표준시 2:00 p.m.에 실적 발표를 위한 컨퍼런스 콜을 주재합니다. 보도자료와 오디오 전용 웹캐스트 링크는 회사의 투자자 관계 사이트 https://ir.nektar.com/에 게시될 예정입니다. 웹 방송 재방송은 2025년 12월 6일까지 이용 가능합니다. 투자자들은 라이브 콜에 접속하기 위한 다이얼-인 정보와 PIN을 받기 위해 미리 등록해야 합니다.
Nektar (Nasdaq:NKTR) annoncera ses résultats financiers du troisième trimestre 2025 le jeudi 6 novembre 2025 après la fermeture des marchés américains. Howard Robin, Président & CEO, animera une conférence téléphonique à 17 h 00 HE / 14 h 00 PT pour examiner les résultats. Un communiqué de presse et un lien vers une webdiffusion uniquement audio seront publiés sur le site des relations avec les investisseurs de l’entreprise à l’adresse https://ir.nektar.com/. La rediffusion de la webdiffusion sera disponible jusqu’au 6 décembre 2025. Les investisseurs doivent préenregistrer pour recevoir les détails d’accès et un code PIN pour accéder à l’appel en direct.
Nektar (Nasdaq:NKTR) wird seine Finanzergebnisse des dritten Quartals 2025 am Donnerstag, 6. November 2025 nach dem US-Marktschluss bekannt geben. Howard Robin, Präsident und CEO, wird eine Konferenzschaltung um 17:00 Uhr ET / 14:00 Uhr PT leiten, um die Ergebnisse zu besprechen. Eine Pressemitteilung und ein nur-Audio-Webcast-Link werden auf der Investor-Relations-Website des Unternehmens unter https://ir.nektar.com/ veröffentlicht. Die Webcast-Wiederholung steht bis zum 6. Dezember 2025 zur Verfügung. Investoren müssen sich vorab registrieren, um Dial-in-Details und eine PIN für den Zugriff auf den Live-Anruf zu erhalten.
Nektar (Nasdaq:NKTR) ستعلن عن النتائج المالية للربع الثالث من 2025 يوم الخميس 6 نوفمبر 2025 بعد إغلاق السوق الأمريكية. سيتولى هاورد روبين، رئيس مجلس الإدارة والرئيس التنفيذي، عقد مؤتمر عبر الهاتف في الساعة 5:00 مساءً بتوقيت شرق الولايات المتحدة / 2:00 مساءً بتوقيت المحيط الهادئ لاستعراض النتائج. سيتم نشر بيان صحفي ورابط لالبث الصوتي فقط عبر الويب على موقع علاقات المستثمرين للشركة على https://ir.nektar.com/. ستتوفر إعادة تشغيل البث عبر الويب حتى 6 ديسمبر 2025. يجب على المستثمرين التسجيل المسبق لتلقي تفاصيل الاتصال ورقم التعريف الشخصي للوصول إلى المكالمة المباشرة.
Nektar (Nasdaq:NKTR) 将在美股收盘后于 2025 年 11 月 6 日星期四 公布其 2025 年第三季度财务业绩。Howard Robin，总裁兼首席执行官，将主持在 美国东部时间 5:00 p.m. / 太平洋时间 2:00 p.m. 的电话会议以审查业绩。新闻稿和一个 音频仅 webcast 链接将发布在公司投资者关系网站 https://ir.nektar.com/。网络广播回放将持续到 2025 年 12 月 6 日。投资者必须事先注册，以获取拨号详情和进入实时通话的 PIN。
- None.
- None.
This press release and live audio-only webcast of the conference call can be accessed through a link that is posted on the Home Page and Investors section of the Nektar website: https://ir.nektar.com/. The web broadcast of the conference call will be available for replay through December 6, 2025.
To access the conference call, please pre-register at Nektar Earnings Call Registration. All registrants will receive dial-in information and a PIN allowing them to access the live call.
About Nektar Therapeutics
Nektar Therapeutics is a clinical-stage biotechnology company focused on developing treatments that address the underlying immunological dysfunction in autoimmune and chronic inflammatory diseases. Nektar's lead product candidate, rezpegaldesleukin (REZPEG, or NKTR-358), is a novel, first-in-class regulatory T cell stimulator being evaluated in two Phase 2b clinical trials, one in atopic dermatitis, one in alopecia areata, and in one Phase 2 clinical trial in Type 1 diabetes mellitus. Nektar's pipeline also includes a preclinical bivalent tumor necrosis factor receptor type II (TNFR2) antibody and bispecific programs, NKTR-0165 and NKTR-0166, and a modified hematopoietic colony stimulating factor (CSF) protein, NKTR-422. Nektar, together with various partners, is also evaluating NKTR-255, an investigational IL-15 receptor agonist designed to boost the immune system's natural ability to fight cancer, in several ongoing clinical trials.
Nektar is headquartered in San Francisco, California. For further information, visit www.nektar.com and follow us on LinkedIn.
Contacts:
For Investors:
Vivian Wu
VWu@nektar.com
Corey Davis, Ph.D.
LifeSci Advisors, LLC
cdavis@lifesciadvisors.com
212-915-2577
Ahu Demir, Ph.D.
LifeSci Advisors, LLC
ademir@lifesciadvisors.com
212-915-3820
For Media:
Jonathan Pappas
LifeSci Communications
857-205-4403
jpappas@lifescicomms.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/nektar-to-announce-financial-results-for-the-third-quarter-on-thursday-november-6-2025-after-close-of-us-based-financial-markets-302597142.html
SOURCE Nektar Therapeutics
FAQ
When will Nektar (NKTR) report third-quarter 2025 results?
What time is the Nektar (NKTR) Q3 2025 conference call and who is hosting?
How can investors access the Nektar (NKTR) earnings webcast and replay?
Do I need to register to join the Nektar (NKTR) November 6 earnings call?
Where will Nektar (NKTR) publish its Q3 2025 press release and supplemental materials?
